 |
|
| CURRENT OPINION IN PHARMACOLOGY
| |
| | |
|
|
Editors-in-Chief:
N.G. Bowery, R. Ruffolo
See editorial board for all editors information
Sign up for the Pharmacology Newsletters
Sign up here!
Description
The Current Opinion journals were developed out of the recognition that it is increasingly difficult for specialists to keep up to date
with the expanding volume of information published in their subject. In Current Opinion in Pharmacology, we help the reader by providing
in a systematic manner:
1. The views of experts on current advances in pharmacology in a clear and readable form.
2. Evaluations
of the most interesting papers, annotated by experts, from the great wealth of original publications
Division of the subject into
sections
The subject of pharmacology is divided into themed sections, each of which is reviewed once a year. The amount of space
devoted to each section is related to its importance.
Neurosciences • Cardiovascular and renal • Respiratory • Musculoskeletal • Cancer • Immunomodulation • Anti-infectives • New technologies • Gastrointestinal • Endocrine and metabolic
diseases
Selection of topics to be reviewed
Section Editors, who are major authorities in the field, are appointed by the
Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that
all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected.
Reviews
Authors write short review articles in which they present recent developments in their subject, emphasising the
aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be
most interesting from all those published in their topic over the previous year.
Editorial Overview
Section Editors write
a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting
developments.
Ethics in Publishing: General Statement
The Editor(s) and Publisher of this Journal believe that there
are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct',
these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which
has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete
manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal
for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines
dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights,
conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances
and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event
of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts
of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's
institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's
work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must
include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such
information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging
the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict.
For more information,
please refer to:  http://www.elsevier.com/wps/find/authorshome.authors/conflictsofinterest
Bibliographic & ordering information
ISSN: 1471-4892
Imprint: CURRENT OPINION
Commenced publication 2001
Subscriptions for the year 2009,
Volume 9,
6 issues
Institutional online access: ScienceDirect eSelect
For purchase of online access to this journal on ScienceDirect.
Personal price: Order form
JPY 36,900 for Japan
EUR 304 for European countries and Iran
USD 331 for all countries except Europe, Japan and Iran
Institutional price: Order form
EUR 1,531 for European countries and Iran
USD 1,711 for all countries except Europe, Japan and Iran
JPY 212,300 for Japan
Conditions of sale & ordering procedures, and links to our regional sales offices.
For an overview of recently-dispatched issues, see the Journal issue
dispatch dates
Audience
Academic and industrial pharmacologists, students and clinicians interested in advances in pharmacology.
Impact factor of this journal
2007: 6.390
© Journal Citation Reports 2008, published by Thomson Reuters
602/188
Last update: 4 Sep 2008
|
|
| |
| | |
|
|
| |
